• PDF: Delivered by email usually within 48 UK business hours.

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013

  • Publication Date:September 2013
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:106
  • ISBN:1012937

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013" provides data on the Interstitial Cystitis (Painful Bladder Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Interstitial Cystitis (Painful Bladder Syndrome). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Interstitial Cystitis (Painful Bladder Syndrome) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Countries Contributing to Clinical Trials in Middle East and Africa 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Interstitial Cystitis (Painful Bladder Syndrome) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
TARIS BioMedical, Inc. 34
Clinical Trial Overview of TARIS BioMedical, Inc. 34
Urigen Pharmaceuticals, Inc. 35
Clinical Trial Overview of Urigen Pharmaceuticals, Inc. 35
Astellas Pharma Europe B.V. 36
Clinical Trial Overview of Astellas Pharma Europe B.V. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Actavis Specialty Pharmaceuticals Co. 38
Clinical Trial Overview of Actavis Specialty Pharmaceuticals Co. 38
ICStudy, LLC 39
Clinical Trial Overview of ICStudy, LLC 39
Rottapharm|Madaus 40
Clinical Trial Overview of Rottapharm|Madaus 40
Mundipharma Research GmbH & Co. KG 41
Clinical Trial Overview of Mundipharma Research GmbH & Co. KG 41
Lipella Pharmaceuticals, Inc. 42
Clinical Trial Overview of Lipella Pharmaceuticals, Inc. 42
Afferent Pharmaceuticals, Inc. 43
Clinical Trial Overview of Afferent Pharmaceuticals, Inc. 43
ICOS Corporation 44
Clinical Trial Overview of ICOS Corporation 44
Trillium Therapeutics Inc. 45
Clinical Trial Overview of Trillium Therapeutics Inc. 45
Aquinox Pharmaceuticals Inc. 46
Clinical Trial Overview of Aquinox Pharmaceuticals Inc. 46
MediciNova, Inc. 47
Clinical Trial Overview of MediciNova, Inc. 47
Taiho Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 48
Actavis, Inc. 49
Clinical Trial Overview of Actavis, Inc. 49
GlaxoSmithKline plc 50
Clinical Trial Overview of GlaxoSmithKline plc 50
Allergan, Inc. 51
Clinical Trial Overview of Allergan, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
William Beaumont Hospitals 52
Clinical Trial Overview of William Beaumont Hospitals 52
The National Institute of Diabetes and Digestive and Kidney Diseases 53
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 53
Assaf-Harofeh Medical Center 54
Clinical Trial Overview of Assaf-Harofeh Medical Center 54
University of Alabama at Birmingham 55
Clinical Trial Overview of University of Alabama at Birmingham 55
University Hospital Inselspital, Berne 56
Clinical Trial Overview of University Hospital Inselspital, Berne 56
The University of Iowa 57
Clinical Trial Overview of The University of Iowa 57
Beth Israel Deaconess Medical Center 58
Clinical Trial Overview of Beth Israel Deaconess Medical Center 58
The University of Tokyo 59
Clinical Trial Overview of The University of Tokyo 59
Boston Children's Hospital 60
Clinical Trial Overview of Boston Children's Hospital 60
Copenhagen University Hospital at Herlev 61
Clinical Trial Overview of Copenhagen University Hospital at Herlev 61
Kaunas University of Medicine 62
Clinical Trial Overview of Kaunas University of Medicine 62
Northwestern University 63
Clinical Trial Overview of Northwestern University 63
Georgetown University 64
Clinical Trial Overview of Georgetown University 64
CAMC Health System 65
Clinical Trial Overview of CAMC Health System 65
University of Washington 66
Clinical Trial Overview of University of Washington 66
Case Western Reserve University 67
Clinical Trial Overview of Case Western Reserve University 67
Capital District Health Authority, Canada 68
Clinical Trial Overview of Capital District Health Authority, Canada 68
Queen's University 69
Clinical Trial Overview of Queen's University 69
University of Pennsylvania 70
Clinical Trial Overview of University of Pennsylvania 70
Stanford University 71
Clinical Trial Overview of Stanford University 71
Five Key Clinical Profiles 72
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106



List of Tables

Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 11
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 12
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 13
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 14
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2013* 15
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 16
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, E7 Countries, 2013* 20
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by TARIS BioMedical, Inc., 2013* 34
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Urigen Pharmaceuticals, Inc., 2013* 35
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe B.V., 2013* 36
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 37
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis Specialty Pharmaceuticals Co., 2013* 38
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by ICStudy, LLC, 2013* 39
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rottapharm|Madaus, 2013* 40
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma Research GmbH & Co. KG, 2013* 41
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lipella Pharmaceuticals, Inc., 2013* 42
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Afferent Pharmaceuticals, Inc., 2013* 43
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by ICOS Corporation, 2013* 44
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Trillium Therapeutics Inc., 2013* 45
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aquinox Pharmaceuticals Inc., 2013* 46
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2013* 47
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2013* 48
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis, Inc., 2013* 49
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 50
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 51
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2013* 52
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 53
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2013* 54
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 55
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2013* 56
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Iowa, 2013* 57
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 58
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2013* 59
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2013* 60
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital at Herlev, 2013* 61
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaunas University of Medicine, 2013* 62
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 63
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2013* 64
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2013* 65
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2013* 66
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2013* 67
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2013* 68
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2013* 69
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 70
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 71



List of Figures

Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 12
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 13
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 14
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 15
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 104
+44 20 8816 8548

Ask a question about Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013

Enter the characters you see in the picture below
Captcha